Sutton Wealth Advisors Inc. - GSK PLC ownership

GSK PLC's ticker is and the CUSIP is 37733W204. A total of 2 filers reported holding GSK PLC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of GSK PLC
ValueSharesWeighting
Q3 2023$227,469
+1.0%
6,275
-0.7%
0.11%
+2.8%
Q2 2023$225,280
+7.4%
6,321
+7.2%
0.11%
-2.7%
Q1 2023$209,780
+1.3%
5,8960.0%0.11%
+41.8%
Q4 2022$207,185
-12.7%
5,896
-26.9%
0.08%
-18.6%
Q3 2022$237,294
+89.1%
8,063
+179.8%
0.10%
+94.0%
Q2 2022$125,453
+90.6%
2,882
+90.7%
0.05%
+117.4%
Q1 2022$65,819
+973.7%
1,511
+987.1%
0.02%
+1050.0%
Q4 2021$6,130
+15.4%
1390.0%0.00%0.0%
Q3 2021$5,311
-4.0%
1390.0%0.00%0.0%
Q2 2021$5,535
+11.6%
1390.0%0.00%0.0%
Q1 2021$4,961
-8.9%
139
-6.1%
0.00%0.0%
Q4 2020$5,446
+4.1%
148
+6.5%
0.00%
-33.3%
Q3 2020$5,232
-7.7%
1390.0%0.00%0.0%
Q2 2020$5,670
+7.7%
1390.0%0.00%0.0%
Q1 2020$5,267
-19.4%
1390.0%0.00%0.0%
Q4 2019$6,532
+10.1%
1390.0%0.00%0.0%
Q3 2019$5,933
+6.7%
1390.0%0.00%0.0%
Q2 2019$5,563
-48.6%
139
-46.3%
0.00%
-50.0%
Q1 2019$10,824
+9.4%
2590.0%0.01%0.0%
Q4 2018$9,896
-58.0%
259
-55.9%
0.01%
-60.0%
Q3 2018$23,580
-0.3%
5870.0%0.02%
-6.2%
Q2 2018$23,662
+3.2%
5870.0%0.02%0.0%
Q1 2018$22,934
+10.1%
5870.0%0.02%
+6.7%
Q4 2017$20,821
-44.3%
587
-36.2%
0.02%
-48.3%
Q3 2017$37,352
-5.8%
9200.0%0.03%
-6.5%
Q2 2017$39,670
+2.3%
9200.0%0.03%
-3.1%
Q1 2017$38,787
+9.5%
9200.0%0.03%0.0%
Q4 2016$35,429
-2.1%
920
+9.7%
0.03%
-3.0%
Q3 2016$36,186
-0.5%
8390.0%0.03%
-2.9%
Q2 2016$36,362
+6.9%
8390.0%0.03%
+6.2%
Q1 2016$34,0218390.03%
Other shareholders
GSK PLC shareholders Q3 2016
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 12,444,460$451,11241.96%
Eversept Partners, LP 3,259,342$118,151,14810.00%
Sio Capital Management, LLC 509,000$18,451,2505.71%
Callodine Capital Management, LP 475,000$17,218,7504.80%
EQUITY INVESTMENT CORP 3,277,362$118,804,3733.70%
Clean Yield Group 207,739$7,802,6773.46%
Robinson Value Management, Ltd. 128,116$4,644,2053.46%
Camber Capital Management LP 2,850,000$103,3133.40%
Hillman Capital Management, Inc. 232,864$8,441,3203.25%
Soleus Capital Management, L.P. 943,000$34,183,7503.15%
View complete list of GSK PLC shareholders